Here we provide a selection of scientific publications related to IOZK immunotherapy. You can use the filters to make a selection according to tumor types and methods, or enter search terms.
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-07-22 / Neuro-oncology 2011 Oct;13(10):1049-58https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-07-22 / Neuro-oncology 2011 Oct;13(10):1049-582011-07-22 00:00:002019-02-15 08:46:38Treatment of high-grade glioma in children and adolescents
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-07-19 / Clin. Cancer Res. 2011 Sep;17(17):5725-35https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-07-19 / Clin. Cancer Res. 2011 Sep;17(17):5725-352011-07-19 00:00:002019-02-15 08:49:18Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-07-01 / Immunotherapy 2011 Jul;3(7):805-7https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-07-01 / Immunotherapy 2011 Jul;3(7):805-72011-07-01 00:00:002019-02-15 08:52:17Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-06-28 / Cancer 2012 Jan;118(1):180-7https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-06-28 / Cancer 2012 Jan;118(1):180-72011-06-28 00:00:002011-06-28 00:00:00Reirradiation and hyperthermia for radiation-associated sarcoma
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-06-17 / J. Exp. Clin. Cancer Res. 2011 Jun;30:65https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-06-17 / J. Exp. Clin. Cancer Res. 2011 Jun;30:652011-06-17 00:00:002019-02-15 08:45:33Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-06-15 / Clin. Cancer Res. 2011 Jun;17(12):3884-91https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-06-15 / Clin. Cancer Res. 2011 Jun;17(12):3884-912011-06-15 00:00:002019-02-15 08:52:52Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-06-15 / J Cancer 2011;2:357-9https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-06-15 / J Cancer 2011;2:357-92011-06-15 00:00:002019-02-15 08:52:49Sipuleucel-T: autologous cellular immunotherapy for men with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg002011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr 2533)https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg2011-06-04 / J Clin Oncol 29: 2011 (suppl; abstr 2533)2011-06-04 00:00:002011-06-04 00:00:00A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.
Challenges in dendritic cells-based therapeutic vaccination in HIV-1 infection Workshop in dendritic cell-based vaccine clinical trials in HIV-1
Treatment of high-grade glioma in children and adolescents
Serum selenium concentration at diagnosis and outcome in patients with haematological malignancies
Route of administration modulates the induction of dendritic cell vaccine-induced antigen-specific T cells in advanced melanoma patients
Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer
A phase I/II clinical trial investigating the adverse and therapeutic effects of a postoperative autologous dendritic cell tumor vaccine in patients with malignant glioma
Reirradiation and hyperthermia for radiation-associated sarcoma
Radiation combined with hyperthermia induces HSP70-dependent maturation of dendritic cells and release of pro-inflammatory cytokines by dendritic cells and macrophages
Prostate cancer immunotherapy
Dendritic cell (DC) vaccination with low dose temozolomide phase I/II trial in melanoma patients: Preliminary data on peripheral blood regulatory t-cells (Treg) and DC-TEM8 expression modulations.
Mature autologous dendritic cell vaccines in advanced non-small cell lung cancer: a phase I pilot study
Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer
Immunotherapy for prostate cancer: recent advances, lessons learned, and areas for further research
Sipuleucel-T: autologous cellular immunotherapy for men with asymptomatic or minimally symptomatic metastatic castrate resistant prostate cancer
Recent advances in immunotherapy for the treatment of prostate cancer
Improvement of dendritic cell therapy in glioblastoma multiforme WHO 4 by Newcastle disease virus.
Results of a phase I/II clinical trial of BPX-101, a novel drug-activated dendritic cell (DC) vaccine for metastatic castration-resistant prostate cancer (mCRPC).
Pilot immunotherapy trial in high-risk pediatric sarcomas.
Melanoma patients treated with dendritic cell vaccination, interleukin-2, and metronomic cyclophosphamide: Results from a phase II trial.
A dendritic cell-based vaccine effects on T-cell responses compared with a viral vector vaccine when administered to patients following resection of colorectal metastases in a randomized phase II study.